IP Library Granted Patent US 12,357,671
Granted Patent B2
US 12,357,671 · App. 17/898,223 · Granted Jul 15, 2025

Compositions and methods for invasive and non-invasive procedural skincare

Inventors: John A. Garruto (Carlsbad, CA); Alan David Widgerow (Carlsbad, CA)
Assignee: Alastin Skincare, Inc.
A61K38/08A61K8/26A61K8/37A61K8/416A61K8/42A61K8/4973A61K8/498A61K8/553A61K8/585A61K8/602A61K8/64A61K8/891A61K8/894A61K8/97A61K9/0014A61K31/01A61K31/047A61K31/16A61K31/231A61K31/353A61K31/47A61K31/685A61K31/695A61K31/7048A61K31/74A61K36/05A61K36/28A61K38/06A61K47/14A61K47/186A61K47/22A61K47/24A61K47/34A61Q19/00A61Q19/08A61K2300/00A61K2800/5922A61K2800/594A61K2800/75A61K2800/884
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,671
App. No.
17/898,223
Granted
Jul 15, 2025
Kind
B2
Abstract

Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

Claims (35)

1. A topical composition, comprising:

a tripeptide-1 present at 0.5-50 ppm; and

a hexapeptide-12 present at 0.5-50 ppm,

wherein the tripeptide-1 and hexapeptide-12 synergistically promote skin repair or wound healing.

2. The topical composition of claim 1 , wherein the tripeptide-1 comprises palmitoyl tripeptide-1, myristoyl tripeptide-1, or a combination thereof.

3. The topical composition of claim 1 , wherein the hexapeptide-12 comprises palmitoyl hexapeptide-12, myristoyl hexapeptide-12, or a combination thereof.

4. The topical composition of claim 1 , wherein the topical composition is in the form of a cream.

5. The topical composition of claim 1 , wherein the tripeptide-1 is present at a concentration of 1-10 ppm.

6. The topical composition of claim 1 , wherein the hexapeptide-12 is present at a concentration of 1-10 ppm.

7. The topical composition of claim 1 , wherein the tripeptide-1 is present at a concentration of 1 ppm to 6 ppm.

8. The topical composition of claim 1 , wherein the hexapeptide-12 is present at a concentration of 1 ppm to 6 ppm.

9. The topical composition of claim 1 , wherein the composition further comprises an excipient selected from: caprylic/capric triglyceride, cetyl ethylhexanoate, cetearyl alcohol, squalane, niacinamide, dimethicone, cetearyl glucoside, glyceryl stearate, PEG-100 stearate, propanediol, ceramide 3, phytosterols, Butyrospermum parklii (shea butter), Olea europaea (olive) fruit oil, sodium hyaluronate, beta-glucan, hydrolyzed pea protein, Dunaliella salina extract, xylitylglucoside, anhydroxylitol, xylitol, glycerin, lecithin, caprylyl glycol, caprylhydroxamic acid, xanthan gum, disodium EDTA, ethylhexylglycerin, phenoxyethanol, or any combination thereof.

10. The topical composition of claim 1 , further comprising a tetrapeptide having the following amino acid sequence: GQPR.

11. A topical composition for application to skin around an eye, comprising:

0.5 ppm to 50 ppm of a tripeptide-1;

0.5 ppm to 50 ppm of a hexapeptide-12;

a tetrapeptide; and

at least one excipient selected from: caprylic/capric triglyceride, cetyl ethylhexanoate, cetearyl alcohol, squalane, niacinamide, dimethicone, cetearyl glucoside, glyceryl stearate, PEG-100 stearate, propanediol, ceramide 3, phytosterols, Butyrospermum parklii (shea butter), Olea europaea (olive) fruit oil, sodium hyaluronate, beta-glucan, hydrolyzed pea protein, Dunaliella salina extract, xylitylglucoside, anhydroxylitol, xylitol, glycerin, lecithin, caprylyl glycol, caprylhydroxamic acid, xanthan gum, disodium EDTA, ethylhexylglycerin, phenoxyethanol, or any combination thereof,

wherein the tripeptide-1 and the hexapeptide-12 synergistically promote skin repair or wound healing.

12. The topical composition of claim 11 , wherein the tetrapeptide comprises an amino acid sequence selected from: GQPR, KTFK, AQTR, or RSRK.

13. The topical composition of claim 12 , wherein the tetrapeptide comprises the amino acid sequence: glycine-glutamine-proline-arginine (GQPR).

14. The topical composition of claim 11 , wherein:

the tripeptide-1 comprises palmitoyl tripeptide-1; and

the hexapeptide-12 comprises palmitoyl hexapeptide-12.

15. The topical composition of claim 14 , wherein the tetrapeptide comprises palmitoyl tetrapeptide-7.

16. The topical composition of claim 11 , wherein any of the tripeptide-1, the hexapeptide-12, or the tetrapeptide is functionalized with palmitoyl or myristoyl group.

17. The topical composition of claim 11 , wherein the topical composition promotes skin restoration around the eye.

18. The topical composition of claim 11 , wherein the topical composition brightens skin around the eye.

19. A topical composition for application to skin around an eye, comprising:

0.5 ppm to 50 ppm of a tripeptide-1;

0.5 ppm to 50 ppm of a hexapeptide-12;

a tetrapeptide-7; and

at least one excipient selected from the group consisting of: of cyclopentasiloxane, tocopherol, caprylic/capri triglyceride, glyceryl stearate, PEG-100 stearate, dimethicone, carbomer, polyacrylate-13, disodium EDTA, glycerin, phenoxyethanol, ethylhexylglycerin, phospholipids, polysorbate 20, butylene glycol, or combinations thereof,

wherein the tripeptide-1 and the hexapeptide-12 synergistically promote skin repair or wound healing.

20. The topical composition of claim 19 , further comprising a buffer, wherein the buffer comprises at least one pH modifying agent selected from the group consisting of: calcium hydroxide, sodium hydroxide, potassium hydroxide, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2022
From: GARRUTO, JOHN A.; WIDGEROW, ALAN DAVID
To: ALASTIN SKINCARE, INC.,
Reel/Frame 060937/0352 →
Continuity (8)
Continuation 17192494 · Mar 4, 2021
Continuation 16870643 · May 8, 2020
Continuation 16293467 · Mar 5, 2019
Continuation 16004259 · Jun 8, 2018
Continuation 15423530 · Feb 2, 2017
Provisional Application 62303332 · Mar 3, 2016
Provisional Application 62291376 · Feb 4, 2016
Related Publication 20240016880A1 · Jan 18, 2024
References Cited (396)
US 3299037A · Boissonnas et al. · 1967 [cited by applicant]
US 3415805A · Siedel et al. · 1968 [cited by applicant]
US 5534420A · Debono et al. · 1996 [cited by applicant]
US 5814610A · Bab et al. · 1998 [cited by applicant]
US 5993787A · Sun et al. · 1999 [cited by applicant]
US 6939854B2 · Priestley · 2005 [cited by applicant]
US 6974799B2 · Lintner · 2005 [cited by applicant]
US 7361634B2 · Trotter et al. · 2008 [cited by applicant]
US 7544375B1 · Bellin et al. · 2009 [cited by applicant]
US 7566464B2 · Belfer · 2009 [cited by applicant]
US 7632527B2 · Jochim et al. · 2009 [cited by applicant]
US 7750115B2 · Oka et al. · 2010 [cited by applicant]
US 7772196B2 · Yedgar · 2010 [cited by applicant]
US 7943156B2 · Domenech et al. · 2011 [cited by applicant]
US 8021695B2 · Gruber · 2011 [cited by applicant]
US 8025907B2 · Belfer · 2011 [cited by applicant]
US 8067370B2 · Trotter et al. · 2011 [cited by applicant]
US 8071139B2 · Widgerow · 2011 [cited by applicant]
US 8076312B2 · Yedgar · 2011 [cited by applicant]
US 8183204B2 · Pickart · 2012 [cited by applicant]
US 8304393B2 · Oka et al. · 2012 [cited by applicant]
US 8394371B2 · Laurent-Applegate et al. · 2013 [cited by applicant]
US 8449879B2 · Laurent-Applegate et al. · 2013 [cited by applicant]
US 8529925B2 · Alexiades-Armenakas · 2013 [cited by applicant]
US 8530426B2 · Lintner et al. · 2013 [cited by applicant]
US 8575106B2 · Santhanam et al. · 2013 [cited by applicant]
US 8591961B2 · Widgerow · 2013 [cited by applicant]
US 8697656B2 · Fournial et al. · 2014 [cited by applicant]
US 8710010B2 · Van Den Nest et al. · 2014 [cited by applicant]
US 8710011B2 · Garcia Sanz et al. · 2014 [cited by applicant]
US 8796315B2 · McCord · 2014 [cited by applicant]
US 8815266B2 · Serraima et al. · 2014 [cited by applicant]
US 8901103B2 · Yedgar · 2014 [cited by applicant]
US 8906426B2 · Galderisi · 2014 [cited by applicant]
US 8916539B2 · Yedgar et al. · 2014 [cited by applicant]
US 8946166B2 · Garcia Sanz et al. · 2015 [cited by applicant]
US 8962565B2 · Dal Farra et al. · 2015 [cited by applicant]
US 8993716B2 · Serraima et al. · 2015 [cited by applicant]
US 9000033B2 · Gruber · 2015 [cited by applicant]
US 9067967B2 · Garcia et al. · 2015 [cited by applicant]
US 9078903B2 · Laurent-Applegate et al. · 2015 [cited by applicant]
US 9144434B1 · Rodan et al. · 2015 [cited by applicant]
US 9180157B2 · Widgerow · 2015 [cited by applicant]
US 9180158B2 · Widgerow · 2015 [cited by applicant]
US 9248160B1 · Obagi et al. · 2016 [cited by applicant]
US 9265792B2 · Riley · 2016 [cited by applicant]
US 9266921B2 · Anton et al. · 2016 [cited by applicant]
US 9278122B2 · Laurent-Applegate et al. · 2016 [cited by applicant]
US 9315564B2 · Serraima et al. · 2016 [cited by applicant]
US 9333152B2 · Ferrer Montiel et al. · 2016 [cited by applicant]
US 9364414B2 · Domloge et al. · 2016 [cited by applicant]
US 9376659B2 · Rao et al. · 2016 [cited by applicant]
US 9408881B2 · Gruber et al. · 2016 [cited by applicant]
US 9434764B2 · Abdel-Malek et al. · 2016 [cited by applicant]
US 9486409B2 · Edelson et al. · 2016 [cited by applicant]
US 9526679B2 · Jang · 2016 [cited by applicant]
US 9725483B2 · Anton et al. · 2017 [cited by applicant]
US 9834580B2 · Abdel-Malek et al. · 2017 [cited by applicant]
US 10086035B2 · Garruto et al. · 2018 [cited by applicant]
US 10286030B2 · Garruto · 2019 [cited by examiner]
US 10493011B2 · Widgerow et al. · 2019 [cited by applicant]
US 10688147B2 · Garruto · 2020 [cited by examiner]
US 11103455B2 · Garruto et al. · 2021 [cited by applicant]
US 11426443B2 · Garruto · 2022 [cited by examiner]
US 11429442B2 · Gummaraju · 2022 [cited by examiner]
US 20030166571A1 · Judd · 2003 [cited by applicant]
US 20030223938A1 · Nagy et al. · 2003 [cited by applicant]
US 20040043047A1 · Dumas et al. · 2004 [cited by applicant]
US 20040120918A1 · Lintner et al. · 2004 [cited by applicant]
US 20050063932A1 · Dilallo et al. · 2005 [cited by applicant]
US 20050244483A1 · Maruyama · 2005 [cited by applicant]
US 20060110355A1 · Blin · 2006 [cited by applicant]
US 20060198800A1 · Dilallo et al. · 2006 [cited by applicant]
US 20070048245A1 · Belfer · 2007 [cited by applicant]
US 20070110731A1 · Riley · 2007 [cited by applicant]
US 20080044373A1 · Ilekti et al. · 2008 [cited by applicant]
US 20080107679A1 · Dilallo et al. · 2008 [cited by applicant]
US 20080152606A1 · Reinhart et al. · 2008 [cited by applicant]
US 20080166313A1 · Jochim et al. · 2008 [cited by applicant]
US 20080166314A1 · Jochim et al. · 2008 [cited by applicant]
US 20080171011A1 · Jochim et al. · 2008 [cited by applicant]
US 20080171030A1 · Jochim et al. · 2008 [cited by applicant]
US 20080171031A1 · Jochim et al. · 2008 [cited by applicant]
US 20080175928A1 · Jochim et al. · 2008 [cited by applicant]
US 20080181974A1 · Cauchard et al. · 2008 [cited by applicant]
US 20080213300A1 · Jochim et al. · 2008 [cited by applicant]
US 20090047226A1 · Teckenbrock et al. · 2009 [cited by applicant]
US 20090186826A1 · Lintner et al. · 2009 [cited by applicant]
US 20090285770A1 · Laboureau · 2009 [cited by applicant]
US 20100000472A1 · Siklosi · 2010 [cited by applicant]
US 20100021401A1 · Sallander · 2010 [cited by applicant]
US 20100183723A1 · Laurent-Applegate et al. · 2010 [cited by applicant]
US 20100189795A1 · Dreher · 2010 [cited by applicant]
US 20100316745A1 · Pellicier et al. · 2010 [cited by applicant]
US 20100322983A1 · Griffiths-Brophy et al. · 2010 [cited by applicant]
US 20110005737A1 · Plata · 2011 [cited by applicant]
US 20110020242A1 · Zheng et al. · 2011 [cited by applicant]
US 20110052676A1 · Gruber · 2011 [cited by applicant]
US 20110059907A1 · Gupta et al. · 2011 [cited by applicant]
US 20110091420A1 · Liu et al. · 2011 [cited by applicant]
US 20110158922A1 · Dupont et al. · 2011 [cited by applicant]
US 20110177140A1 · Voegeli et al. · 2011 [cited by applicant]
US 20120021029A1 · Garcia Sanz et al. · 2012 [cited by applicant]
US 20120045405A1 · Gilman et al. · 2012 [cited by applicant]
US 20120076842A1 · Fournial · 2012 [cited by examiner]
US 20120128755A1 · Gruber et al. · 2012 [cited by applicant]
US 20120277313A1 · Kwon et al. · 2012 [cited by applicant]
US 20130129691A1 · Laurent-Applegate et al. · 2013 [cited by applicant]
US 20130224131A1 · Voegeli et al. · 2013 [cited by applicant]
US 20130337088A1 · Widgerow · 2013 [cited by applicant]
US 20140127286A1 · Doucet et al. · 2014 [cited by applicant]
US 20140178315A1 · Gruber et al. · 2014 [cited by applicant]
US 20140242134A1 · Khoshdel et al. · 2014 [cited by applicant]
US 20140309173A1 · Dreher · 2014 [cited by applicant]
US 20140315995A1 · Dreher · 2014 [cited by applicant]
US 20140364819A1 · Vandelden · 2014 [cited by applicant]
US 20150050331A1 · Needleman · 2015 [cited by applicant]
US 20150057244A1 · Yedgar et al. · 2015 [cited by applicant]
US 20150157728A1 · Modi · 2015 [cited by applicant]
US 20150183823A1 · García Sanz et al. · 2015 [cited by applicant]
US 20150202139A1 · Friedman · 2015 [cited by applicant]
US 20150209282A1 · Chu et al. · 2015 [cited by applicant]
US 20150342852A1 · Van Den Nest et al. · 2015 [cited by applicant]
US 20150342854A1 · Shibuya et al. · 2015 [cited by applicant]
US 20160000858A1 · Tittl et al. · 2016 [cited by applicant]
US 20160006543A1 · Winstead et al. · 2016 [cited by applicant]
US 20160008263A1 · Mendoza · 2016 [cited by applicant]
US 20160030321A1 · Dreher · 2016 [cited by applicant]
US 20160058693A1 · Widgerow · 2016 [cited by applicant]
US 20160058816A1 · Widgerow · 2016 [cited by applicant]
US 20160075738A1 · Ferrer Montiel et al. · 2016 [cited by applicant]
US 20170001438A1 · Seto et al. · 2017 [cited by applicant]
US 20170081508A1 · Daniere et al. · 2017 [cited by applicant]
US 20170101438A1 · Sanz et al. · 2017 [cited by applicant]
US 20170135930A1 · Korth · 2017 [cited by applicant]
US 20170157014A1 · Peschard et al. · 2017 [cited by applicant]
US 20170202769A1 · Pilant · 2017 [cited by applicant]
US 20170281507A1 · Idkowiak-Baldys et al. · 2017 [cited by applicant]
US 20170281508A1 · Idkowiak-Baldys et al. · 2017 [cited by applicant]
US 20170304178A1 · Idkowiak-Baldys et al. · 2017 [cited by applicant]
US 20180066016A1 · Abdel-Malek et al. · 2018 [cited by applicant]
US 20200338154A1 · Garruto et al. · 2020 [cited by applicant]
US 20210290515A1 · Widgerow et al. · 2021 [cited by applicant]
CA 2768653A1 · 2011 [cited by applicant]
CA 2895387A1 · 2014 [cited by applicant]
CN 103505377A · 2014 [cited by applicant]
CN 103601792B · 2014 [cited by applicant]
CN 104069043A · 2014 [cited by applicant]
CN 104523449A · 2015 [cited by applicant]
CN 104523554A · 2015 [cited by applicant]
CN 104586695A · 2015 [cited by applicant]
CN 104622779A · 2015 [cited by applicant]
CN 107375041A · 2017 [cited by applicant]
DE 102004050563A1 · 2006 [cited by applicant]
DE 102004055541A1 · 2006 [cited by applicant]
DE 102004057405A1 · 2006 [cited by applicant]
DE 102004057406A1 · 2006 [cited by applicant]
DE 102005063179A1 · 2006 [cited by applicant]
DE 102006046076A1 · 2007 [cited by applicant]
DE 102005056157A1 · 2007 [cited by applicant]
DE 102005063062A1 · 2007 [cited by applicant]
DE 102005063178A1 · 2007 [cited by applicant]
DE 102006004955A1 · 2007 [cited by applicant]
DE 102006020380A1 · 2007 [cited by applicant]
DE 102006040903A1 · 2008 [cited by applicant]
DE 102006041291A1 · 2008 [cited by applicant]
DE 102007022448A1 · 2008 [cited by applicant]
DE 102007024381A1 · 2008 [cited by applicant]
DE 102006049672A1 · 2008 [cited by applicant]
DE 102006049674A1 · 2008 [cited by applicant]
DE 102006049675A1 · 2008 [cited by applicant]
DE 102007022449A1 · 2008 [cited by applicant]
DE 102006058611A1 · 2008 [cited by applicant]
DE 102006060439A1 · 2008 [cited by applicant]
DE 102006061829A1 · 2008 [cited by applicant]
DE 102006062438A1 · 2008 [cited by applicant]
DE 102006062501A1 · 2008 [cited by applicant]
DE 102006062566A1 · 2008 [cited by applicant]
DE 102007024384A1 · 2008 [cited by applicant]
DE 102007031452A1 · 2009 [cited by applicant]
DE 102008028821A1 · 2009 [cited by applicant]
DE 102008061045A1 · 2009 [cited by applicant]
DE 102008032179A1 · 2010 [cited by applicant]
DE 102009026718A1 · 2010 [cited by applicant]
DE 102008053883A1 · 2010 [cited by applicant]
DE 102008053884A1 · 2010 [cited by applicant]
DE 102008059703A1 · 2010 [cited by applicant]
DE 102008061044A1 · 2010 [cited by applicant]
DE 102008062398A1 · 2010 [cited by applicant]
DE 102009037537A1 · 2010 [cited by applicant]
DE 102009037900A1 · 2010 [cited by applicant]
DE 102009039393A1 · 2010 [cited by applicant]
DE 102009045981A1 · 2010 [cited by applicant]
DE 102008061340A1 · 2010 [cited by applicant]
DE 102009002226A1 · 2010 [cited by applicant]
DE 102009002227A1 · 2010 [cited by applicant]
DE 102009002287A1 · 2010 [cited by applicant]
DE 102009017612A1 · 2010 [cited by applicant]
DE 102009026414A1 · 2010 [cited by applicant]
DE 102009027024A1 · 2010 [cited by applicant]
DE 102009029813A1 · 2010 [cited by applicant]
DE 102010027180A1 · 2011 [cited by applicant]
DE 102010028418A1 · 2011 [cited by applicant]
DE 102010063585A1 · 2012 [cited by applicant]
DE 102011084904A1 · 2012 [cited by applicant]
DE 102011087999A1 · 2012 [cited by applicant]
DE 102012222967A1 · 2013 [cited by applicant]
DE 102012222764A1 · 2013 [cited by applicant]
EP 2266529A2 · 2010 [cited by applicant]
EP 2514403A1 · 2012 [cited by applicant]
EP 2740484A1 · 2014 [cited by applicant]
EP 2792684A1 · 2014 [cited by applicant]
FR 2668365A1 · 1992 [cited by applicant]
JP 2011246372A · 2011 [cited by applicant]
JP 2015510919A · 2015 [cited by applicant]
JP 2016014054A · 2016 [cited by applicant]
RU 2591789C1 · 2016 [cited by applicant]
WO WO9910374A1 · 1999 [cited by applicant]
WO WO2005016364A1 · 2005 [cited by applicant]
WO WO2005048968A1 · 2005 [cited by applicant]
WO WO2006131234A1 · 2006 [cited by applicant]
WO WO2007000214A1 · 2007 [cited by applicant]
WO WO2007017196A2 · 2007 [cited by applicant]
WO WO2007059822A1 · 2007 [cited by applicant]
WO WO2007078056A1 · 2007 [cited by applicant]
WO WO2008003685A1 · 2008 [cited by applicant]
WO WO2008058943A2 · 2008 [cited by applicant]
WO WO2008065072A1 · 2008 [cited by applicant]
WO WO2008090226A2 · 2008 [cited by applicant]
WO WO2008151257A2 · 2008 [cited by applicant]
WO WO2008155382A2 · 2008 [cited by applicant]
WO WO2008155391A2 · 2008 [cited by applicant]
WO WO2009026949A1 · 2009 [cited by applicant]
WO WO2009059205A1 · 2009 [cited by applicant]
WO WO2009114959A1 · 2009 [cited by applicant]
WO WO2010019939A1 · 2010 [cited by applicant]
WO WO2010037553A1 · 2010 [cited by applicant]
WO WO2010049011A2 · 2010 [cited by applicant]
WO WO2010049389A1 · 2010 [cited by applicant]
WO WO2010049390A1 · 2010 [cited by applicant]
WO WO2010049457A2 · 2010 [cited by applicant]
WO WO2010118880A1 · 2010 [cited by applicant]
WO WO2011028673A2 · 2011 [cited by applicant]
WO WO2012010684A2 · 2012 [cited by applicant]
WO WO2012010685A2 · 2012 [cited by applicant]
WO WO2012044745A2 · 2012 [cited by applicant]
WO WO2012098116A1 · 2012 [cited by applicant]
WO WO2012130775A1 · 2012 [cited by applicant]
WO WO2012143845A2 · 2012 [cited by applicant]
WO WO2012164488A2 · 2012 [cited by applicant]
WO WO2013060707A2 · 2013 [cited by applicant]
WO WO2013075017A1 · 2013 [cited by applicant]
WO WO2013091975A1 · 2013 [cited by applicant]
WO WO2013092080A1 · 2013 [cited by applicant]
WO WO2014081845A2 · 2014 [cited by applicant]
WO WO2014090524A2 · 2014 [cited by applicant]
WO WO2014110613A1 · 2014 [cited by applicant]
WO WO2014120793A1 · 2014 [cited by applicant]
WO WO2014140890A2 · 2014 [cited by applicant]
WO WO2016007314A1 · 2016 [cited by applicant]
WO WO2016046848A2 · 2016 [cited by applicant]
WO WO2016097966A1 · 2016 [cited by applicant]
WO WO2017001625A1 · 2017 [cited by applicant]
WO WO2017136600A1 · 2017 [cited by applicant]
WO WO2017216177A1 · 2017 [cited by applicant]
WO WO2019028275A1 · 2019 [cited by applicant]
Shirakata (Yuji Shirakata, et al, Heparin-binding EGF-like Growth Factor Accelerates Keratinocyte Migration and Skin Wound Healing, 118 J Cell Sci., 2363 (Year: 2005). [cited by examiner]
Active Concepts. AC Dermal Respiratory Factor Advanced PF. Technical Data Sheet. (4 pgs.) (2014). [cited by applicant]
Al-Rimawi et al. Formulation and evaluation of a moisturizing day cream containing olive leaves extract. Int J Devel Res 4(10):1996-2000 (2014). [cited by applicant]
Alkemade et al. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. Journal of Cell Science 107:2335-2342 (1994). [cited by applicant]
Ashcroft et al. Age-Related Changes in the Temporal And Spatial Distributions of Fibrillin and Elastin Mrnas and Proteins in Acute Cutaneous Wounds of Healthy Humans. Journal of Pathology 183:80-89 (1997). [cited by applicant]
Bani et al. Histological and Ultrastructural Effects of Ultrasound-induced Cavitation on Human Skin Adipose Tissue. Plast Reconstr Surg Glob Open 1(6):e41 (2013). [cited by applicant]
Bauters et al. Gelatinase A (MMP2) promotes marine adipogenesis. Biochimica et Biophysica Acta (BBA) General Subjects 1850:1449-1456 (2015). [cited by applicant]
Bekker et al. Relating rheological measurements to primary and secondary skin feeling when mineral-based and Fischer-Tropsch wax-based cosmetic emulsions and jellies are applied to the skin. Int J Cosme! Sci 35(4):354-3… [cited by applicant]
Bitto et al. Long-term IGF-I exposure decreases autophagy and cell viability. PLoS One 5(9):e12592 (10 pages) (2010). [cited by applicant]
Blanchevoye et al. Interaction between the Elastin Peptide VGVAPG and Human Elastin Binding Protein. J Biol Chem 288:1317-1328 (2012). [cited by applicant]
Brandner et al. Caffeine improves barrier function in male skin. International Journal of Cosmetic Science 28:343-347 (2006). [cited by applicant]
Bylka et al. Centella asiatica in cosmetology. Postepy Dermatol Alergol 30(1):46-49 (2013). [cited by applicant]
Cappellano et al. Dermal white adipose tissue renewal is regulated by the PDGFA/AKT axis. Stem Cell Investig 4:23 (3 pages) (2017). [cited by applicant]
Carruthers et al. (2014) “Cryolipolysis and skin tightening” Dermatol Surg., Dec. 2014, vol. 40, Supplemental 12, pp. 184-189. [cited by applicant]
Casas. 2019 ASAPS—Examination of healing and recovery outcomes post cosmetic surgery and non-surgical body contouring procedures with a novel topical body treatment incorporating Tripeptide and Hexapeptide (TriHex) tech… [cited by applicant]
CELLDETOX® Product brochure. Silab (3 pgs.) (2013). [cited by applicant]
Cenizo et al. LOXL as a target to increase the elastin content in adult skin: a dill extract induces the LOXL gene expression. Experimental Dermatology 15:574-581 (2006). [cited by applicant]
Chiang et al. Current concepts related to hypertrophic scarring in burn injuries. Wound Repair Regen 24(3):466-77 (2016). [cited by applicant]
Cho et al. Phosphatidylserine prevents UV-induced decrease of type I procollagen and increase of MMP-1 in dermal fibroblasts and human skin in vivo. J Lipid Res 49(6):1235-1245 (2008). [cited by applicant]
Cianfanelli et al. Ambra1 at a glance. J Cell Sci 128(11):2003-8 (2015). [cited by applicant]
Codogno et al. Atg5: more than an autophagy factor. Nature Cell Biology 8(10):1045-1048 (2006). [cited by applicant]
Database GNPD [Online]: MINTEL; anonymous: Lip Bio-Lipid Concentrate; XP055606868, retrieved from www.gnpd.com, Database accession No. 3434721 (2015). [cited by applicant]
Database GNPD [Online]: MINTEL; anonymous: Skin Softening Toner; XP055606893, retrieved from www.gnpd.com, Database accession No. 2481095 (2014). [cited by applicant]
De Backer et al. Controlling MicroRNAs to Fight Skin Senescence. Cosmetics & Toiletries Available at https://www.cosmeticsandtoiletries.com/research/biology/Controlling-MicroRNAs-to-Fight-Skin-Senescence-367698261.html … [cited by applicant]
Donati et al. Epidermal Wnt/ß-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factors. PNAS USA 111(15):E1501-E1509. (2014). [cited by applicant]
Dow Corning 9040 Silicone Elastomer Blend product Information (7 pgs) (Apr. 3, 2012). [cited by applicant]
Draelos et al. Glycation and Skin Aging: A Review. Cosmetics & Toiletries Magazine (3 pgs.) (Jun. 2011). [cited by applicant]
Driskell et al. Defining dermal adipose tissue. Exp Dermatol 23(9):629-631 (2014). [cited by applicant]
Duncan et al. A prospective study analyzing the application of radiofrequency energy and high- voltage, ultrashort pulse duration electrical fields on the quantitative reduction of adipose tissue. J Cosme! LaserTher 18(… [cited by applicant]
Emami-Razavi et al. Effect of Bentonite on Skin Wound Healing: Experimental Study in the Rat Model. Acta Medica Iranica 44(4):235-240 (2006). [cited by applicant]
ESSENSKIN™ The essential by instinct. Brochure (2 pgs.) (2008). [cited by applicant]
EWG's Skin Deep Cosmetics Database‘System JO Maximizer Shaping Cream’ Nov. 2014 Retrieved from the internet: URL: http:www.ewg.orgskindeepproduct526533System_JO_Maximizer_Shaping_Cream (5 pgs). [cited by applicant]
Extended European Search Report on EP Appl. No. 17748189.2 dated Jul. 25, 2019 (7 pages). [cited by applicant]
Extended European Search Report on EP Appl. No. 18842077.2 dated Jun. 16, 2021 (8 pages). [cited by applicant]
Fligiel et al. Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol 120:842-848 (2003). [cited by applicant]
Floquet et al. Structural Characterization of VGVAPG an Elastin-Derived Peptide. Biolpolymers 76:266-280 (2004). [cited by applicant]
Foster et al., Dermal white adipose tissue undergoes major morphological changes during the spontaneous and induced murine hair follicle cycling: a reappraisal. Archives of Dermatological Research 310(5):453-462. doi: 1… [cited by applicant]
Garibyan et al. Three-dimensional volumetric quantification of fat loss following cryolipolysis. Lasers Surg Med 46(2):75-80 (2014). [cited by applicant]
Gautam, et al. Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8. Sci. Rep. 6, 26278 (2016). [cited by applicant]
Grant et al. Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis. Am J Physiol Endocrinol Metab 309(3):E205-13 (2015). [cited by applicant]
Gregory et al. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113:1-14 (2004). [cited by applicant]
Gruber et al. Modulation of cellular senescence in fibroblasts and dermal papillae cells in vitro. J Cosme! Sci. 64(2):79-87 (2013) (Abstract). [cited by applicant]
Hakozaki et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 147:20-31 (2002). [cited by applicant]
He et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Reports 12(4):358-364 (2011). [cited by applicant]
Hocker et al. Inhibition of autophagy through MAPK14-mediated phosphorylation of ATG5. Autophagy 9(3):426-428 (2013). [cited by applicant]
Ingargiola et al. Cryolipolysis for fat reduction and body contouring: safety and efficacy of current treatment paradigms. Plast Reconstr Surg 135(6):1581-90 (2015). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. No. PCT/US2017/016292 dated May 12, 2017 (14 pages). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. No. PCT/US2018/045045 dated Oct. 10, 2018 (14 pages). [cited by applicant]
International Search Report and Written Opinion on PCT Appl. No. PCT/US2019/044714 dated Dec. 3, 2019 (17 pages). [cited by applicant]
Ito et al. Is the Hair Follicle Necessary for Norm Wound Healing. J Invest Dermatol 128:1059-1061 (2008). [cited by applicant]
Verma et al., Transfollicular drug delivery: current perspectives. Research and Reports in Transdermal Drug Delivery. (17 pages) (2016). [cited by applicant]
Jalian et al. Paradoxical adipose hyperplasia after cryolipolysis. JAMA Dermatol 150(3):317-9 (2014). [cited by applicant]
Johnson et al. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. J Control Release 166(2):124-129 (2013). [cited by applicant]
Johnson et al.: Safety Assessment ofTripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics. Cosmetic Ingredient Review. 37(Supplement 3):90S-102S (2… [cited by applicant]
Jose et al. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomater 10(5):1955-1964 (2014). [cited by applicant]
Katsiki et al. The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts. Rejuvenation Res 10(2):157-172 (2007). [cited by applicant]
Khamlue et al. Skin Wound Healing Promoting Effect of Polysaccharides Extracts from Tremella fuciformis and Auricularia auricula on the ex-vivo Porcine Skin Wound Healing Model. 2012 4th International Conference on Chem… [cited by applicant]
Kilmer et al. Safety and efficacy of cryolipolysis for non-invasive reduction of submental fat. Lasers Surg Med 48(1):3-13 (2016). [cited by applicant]
Kontogianni et al. Olive leaf extracts are a natural source of advanced glycation end product inhibitors. J Med Food 16(9):817-822 (2013). [cited by applicant]
Koo et al. Protection from photodamage by topical application of caffeine after ultraviolet irradiation. Br J Dermatol 156(5):957-964 (2007). [cited by applicant]
Kovac et al. Plantago lanceolata L. water extract induces transition offibroblasts into myofibroblasts and increases tensile strength of healing skin wounds. J Pharm Pharmacol 67(1):117-125 (2015). [cited by applicant]
Kruglikov et al. Skin aging: are adipocytes the next target? Aging (Albany NY) 8(7):1457-1469 (2016). [cited by applicant]
Laatikainen et al. SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and FoxO3a. PLoS One 6(8):e24456 (2011). [cited by applicant]
Lee et al. Protective effect and mechanism of phosphatidylserine in UVB-induced human dermal fibroblasts. Eu J Lipid Sci Technol 115(7):783-790 (2013). [cited by applicant]
Li et al. Antioxidant and anti-inflammatory activities of methanol extracts of Tremella fuciformis and its major phenolic acids. J Food Sci 79(4):C460-468 (2014). [cited by applicant]
Liao et al. Antioxidative activity, moisture retention, film formation, and viscosity stability of Auricularia fuscosuccinea, white strain water extract. Biosci Biotechnol Biochem 78(6):1029-1036 (2014). [cited by applicant]
Liu et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein.Nat Genet. 36(2):178-182 (2004). [cited by applicant]
Luebberding et al. Age-related changes in skin barrier function-quantitative evaluation of 150 female subjects.Int J Cosme! Sci. 35(2):183-190 (2013). [cited by applicant]
Lupo et al. Cosmeceutical peptides. Dermatol Ther 20:343-349 (2007). [cited by applicant]
Mahmoudi et al. Comparing the effects of Bentonite & Calendula on the improvement of infantile diaper dermatitis: A randomized controlled trial. Indian J Med Res 42:742-746 (2015). [cited by applicant]
Maixner et al. Autophagy in Adipose Tissue. Obes Facts. 5(5):710-721 (2012). [cited by applicant]
Manstein et al. Selective cryolysis: A novel method of non-invasive fat removal. Lasers in Surgery and Medicine 40(9):595-604 (2008). [cited by applicant]
Marigliano et al.: Use of peptides in anti-aging functional cosmetology. Household and Personal Care Today. Tekno Scienze. Milano, IT. 4(1):4-11 (2010). [cited by applicant]
Marino et al. Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem 278(6):3671-8 (2003). [cited by applicant]
Mohan et al.: Encapsulation of bioactive whey peptides in soy lecithin-derived nanoliposomes: Influence of peptide molecular weight. ScienceDirect. Food Chemistry 213:143-148 (2016). [cited by applicant]
Nagase Chemtex PIPS; Phosphatidylserine & phosphatidylinositol (4 pgs) (May 2015). [cited by applicant]
Navarrete-Solis et al. A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma. Dermatol Res Pract 2011:379173 (2011). [cited by applicant]
Niod Lip Bio Lipid Concentrate. British Beauty Blogger (9 pages) (2015). [cited by applicant]
Noblesse et al. Lysyl oxidase-like and lysyl oxidase are present in the dermis and epidermis of a skin equivalent and in human skin and are associated to elastic fibers. J Invest Dermatol 122(3):621-630 (2004). [cited by applicant]
Ojima et al. Dynamics of protein secretion during adipocyte differentiation. FEBS Open Bio 6(8):816-26 (2016). [cited by applicant]
Omar. Oleuropein in olive and its pharmacologic effects. Sci Pharm 78(2):133-154 (2010). [cited by applicant]
Park et al. “High-Intensity Focused Ultrasound for the Treatment of Wrinkles and Skin Laxity in Seven Different Facial Areas”, Ann Dermatol., Dec. 2015, 27(6), pp. 688-693. [cited by applicant]
Pereira et al. The role of inflammation in adipocytolytic nonsurgical esthetic procedures for body contouring. Clinical, Cosmetic and Investigational Dermatology 10:57-66 (2017). [cited by applicant]
PHYTOSONIC™ Brochure. Sederma (2 pgs.) (Sep. 2008). [cited by applicant]
Pickart et al. The Human Tripeptide GHKCU in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health. Oxid Med Cell Longev 2012:324832 (2012). [cited by applicant]
Pickart et al.: GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Hindawi Publishing Corp. BioMed Research International. Article ID 648108, 7 pages (2015). [cited by applicant]
Pickart. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 19:969-988 (2008). [cited by applicant]
Plikus et al. Regeneration of fat cells from myofibroblasts during wound healing. Science 355(6326):7 48-752 (2017). [cited by applicant]
Preissig et al. Current laser resurfacing technologies: A review that delves beneath the surface. Semin Plast Surg 26(3):109-116 (2012). [cited by applicant]
PRO-LIPO™ Neo. Smart Lipsome Preparation. LucasMeyer Cosmetics PowerPoint Presentation (25 pgs) (viewed Aug. 2018). [cited by applicant]
Remington. The Science and Practice of Pharmacy. Mack Publishing Company, 19th Edition, 1995. [cited by applicant]
Remington: The science and practice of pharmacy. 20th Edition. Gennaro, Eds. Lippincott VI/illiams & Wilkins, 2000. [cited by applicant]
Resh. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochimica et Biophysica Acta 1451:1-16 (1999). [cited by applicant]
Rigacci et al. Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight. Oncotarget 6(3):35344-35357 (2015). [cited by applicant]
Rivera-Gonzalez et al. Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis. Cell Stem Cell 19(6):738-751 (2016). [cited by applicant]
Rnjak et al. Severe Burn Injuries and the Role of Elastin in the Design of Dermal Substitutes. Tissue Eng Part B Rev 17(2):81-91 (2011). [cited by applicant]
Russell et al. Studies on the antiobesity effect of zinc-alpha2-glycoprotein in the ob/ob mouse. Int J Obes (Land) 35(3):345-354 (2011). [cited by applicant]
Seaman et al. Paradoxical Adipose Hyperplasia and Cellular Effects After Cryolipolysis: A Case Report. Aesthet Surg J 36(1):NP6-13 (2016). [cited by applicant]
Sederma, BIO-BUSTYL: A genuine firmness and tone concentrate for the bust, Feb. 2008, vol. 2 (2 pages). [cited by applicant]
Senior et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 99:870-874 (1984). [cited by applicant]
Shadfar et al. Anatomy and Physiology of the Aging Neck. Facial Plast Surg Clin North Am. 22(2):161-170 (2014). [cited by applicant]
Shirakata et al., “Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing” Journal of Cell Science, vol. 118, No. 11, Jul. 2005, pp. 2363-2370. [cited by applicant]
Simeon et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol 112:957-962 (1999). [cited by applicant]
Simons. Angiogenesis: where do we stand now? Circulation 111(12):1556-1566 (2005). [cited by applicant]
Sinambela et al., Human in vivo study: dermal application of Rutin SmartCrystals® & peptide-loaded liposomes to decrease skin roughness. 4oth Annual Meeting of the Controlled Release Society (2013). [cited by applicant]
Singh et al. Lipophagy: Connecting Autophagy and Lipid Metabolism. Int J Cell Biol. 2012:282041 (2012). [cited by applicant]
Sklirou et al. Hexapeptide-11 is a novel modulator of the proteostasis network in human diploid fibroblasts. Redox Biology 5:205-215 (2015). [cited by applicant]
SymDecanox HA. New Generation of Antioxidant. Symris Brochure (34 pgs) (2015). [cited by applicant]
Takeuchi et al. Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells. Br J Cancer 90(5):1069-75 (2004). [cited by applicant]
Tsai et al. How irritant is water? An overview. Contact Dermatitis 41(6):311-314 (1999). [cited by applicant]
Unisooth PN47. Induchem Switzerland. (15 pgs) (Sep. 21, 2010). [cited by applicant]
Uplevity™. Lipotec. Technical Report (25 pgs) (Jun. 2013). [cited by applicant]
Van Zutphen et al. Lipid droplet autophagy in the yeast [cited by applicant]
Verma et al. Transfollicular drug delivery: current perspectives. Research and Reports in Transdermal Drug Delivery 5:1-17 (2016). [cited by applicant]
Verma. Particle size of liposomes influences dermal delivery of substances into skin. International Journal of Pharmaceutics 258(1-2):141-151 (2003). [cited by applicant]
Wen et al. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis. PNAS USA 111(44):15723-15728 (2014). [cited by applicant]
Widgerow. Chronic wound fluid-thinking outside the box. Wound Repair Regen 19(3):287-291 (2011). [cited by applicant]
Vilchez et al. Marine carotenoids: biological functions and commercial applications. Mar Drugs 9(3):319-333 (2011). [cited by applicant]
Vogt et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126(6):1316-22 (2006). [cited by applicant]
Vural et al. Autophagy in macrophages: impacting inflammation and bacterial infection. Scientifica (Cairo) 2014:825463 (2014). [cited by applicant]
Wang. Lipid droplets, lipophagy, and beyond. Biochim Biophys Acta 1861(8 Pt B):793-805 (2016). [cited by applicant]
Widgerow et al. (2016) “Extracellular matrix modulation: optimizing skin care and rejuvenation procedures” Journal of Drugs in Dermatology, Apr. 2016, vol. 15, issue 4 (Supplement), pp. 63-71. [cited by applicant]
Widgerow et al. A Double-Blind Randomized controlled Trial Evaluation the Efficacy and Tolerability of a Topical body Treatment in Combination With Cryolipolysis Procedures. J Drugs Dermatol 18(4):342-348 (2019). [cited by applicant]
Widgerow et al. Non-Surgical Fat Reduction and Topical Modulation of Adipose Tissue Physiology. J Drugs Dermatol 18(4):375-380 (2019). [cited by applicant]
Widgerow et al. Preoperative Skin Conditioning: Extracellular Matrix Clearance and Skin Bed Preparation, A New Paradigm. Aesthetic Surgery Journal39(S3):S103-S111 (2019). [cited by applicant]
Widgerow. Topical Skin Restoration Technology—Advances in Age Management Strategies. Modern Aesthetics (8 pgs.) (May/Jun. 2016). [cited by applicant]
Wohlrab et al. Niacinamide—Mechanisms of Action and Its Topical Use in Dermatology. Skin Pharmacol Physiol 27:311-315 (2014). [cited by applicant]
Wu et al. Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int J Biol Sci 10(9):1072-83 (2014). [cited by applicant]
Zhang et al. Induction of autophagy is essential for monocyte-macrophage differentiation. Blood 119(12):2895-2905 (2012). [cited by applicant]
Zoumalan. Topical Agents for Scar management: Are They Effective? J Drugs Dermatol 17(4):421-425 (Apr. 2018). [cited by applicant]